These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24215556)

  • 1. Review of laquinimod and its therapeutic potential in multiple sclerosis.
    Thöne J; Gold R
    Expert Opin Pharmacother; 2013 Dec; 14(18):2545-52. PubMed ID: 24215556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis.
    Thöne J; Gold R
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):365-70. PubMed ID: 21306281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
    Thöne J; Linker RA
    Drug Des Devel Ther; 2016; 10():1111-8. PubMed ID: 27042003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral laquinimod treatment in multiple sclerosis.
    Fernández O
    Neurologia; 2011 Mar; 26(2):111-7. PubMed ID: 21163185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
    Thöne J; Ellrichmann G
    Drug Healthc Patient Saf; 2013; 5():37-47. PubMed ID: 23459383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laquinimod in the treatment of relapsing remitting multiple sclerosis.
    Hainke U; Thomas K; Ziemssen T
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):701-9. PubMed ID: 27089834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laquinimod, a new oral autoimmune modulator for the treatment of relapsing-remitting multiple sclerosis.
    Tselis A
    Curr Opin Investig Drugs; 2010 May; 11(5):577-85. PubMed ID: 20419604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
    Constantinescu SE; Constantinescu CS
    Expert Rev Clin Pharmacol; 2016; 9(1):49-57. PubMed ID: 26536299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis.
    Varrin-Doyer M; Zamvil SS; Schulze-Topphoff U
    Exp Neurol; 2014 Dec; 262 Pt A():66-71. PubMed ID: 24731945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral laquinimod therapy in relapsing multiple sclerosis.
    Preiningerova J
    Expert Opin Investig Drugs; 2009 Jul; 18(7):985-9. PubMed ID: 19527103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
    Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):93-9. PubMed ID: 23675607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
    Brück W; Zamvil SS
    Expert Rev Clin Pharmacol; 2012 May; 5(3):245-56. PubMed ID: 22697588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
    Filippi M; Rocca MA; Pagani E; De Stefano N; Jeffery D; Kappos L; Montalban X; Boyko AN; Comi G;
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):851-8. PubMed ID: 24029546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled trial of oral laquinimod for multiple sclerosis.
    Comi G; Jeffery D; Kappos L; Montalban X; Boyko A; Rocca MA; Filippi M;
    N Engl J Med; 2012 Mar; 366(11):1000-9. PubMed ID: 22417253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
    Polman C; Barkhof F; Sandberg-Wollheim M; Linde A; Nordle O; Nederman T;
    Neurology; 2005 Mar; 64(6):987-91. PubMed ID: 15781813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New oral drugs for multiple sclerosis.
    Gasperini C; Ruggieri S
    Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic options for multiple sclerosis.
    Curtin F; Hartung HP
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):91-104. PubMed ID: 24325127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laquinimod therapy in multiple sclerosis: a comprehensive review.
    Kolb-Sobieraj C; Gupta S; Weinstock-Guttman B
    Neurol Ther; 2014 Jun; 3(1):29-39. PubMed ID: 26000222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.